- Global Pharma News & Resources

Global Psychedelic Drugs Market (COVID - 19 Updates) 2021 A look At Current And Upcoming Growth |

Latest added Psychedelic Drugs Market research study by MarketDigits offers detailed product outlook and elaborates market review till 2026. The market Study is segmented by key regions that is accelerating the marketization. At present, the market is sharping its presence and some of the key players in the study are The Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources.

This report studies the Psychedelic Drugs Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the Psychedelic Drugs Market by companies, region, type and end-use industry.

Request for Sample Copy of This Report @

Scroll down 100s of data Tables, charts and graphs spread through Pages and in-depth Table of Content on “Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Salvia, Psilocybin), Route of Administration ( Oral, Injectable, Inhalation), Distribution Channel (Direct Retailers, Online Pharmacies), End-Users (Hospitals, Homecare, Specialty Clinics), Application (Major Depressive Disorder, Resistant depression, Panic disorder, Post-traumatic stress disorder, Opiate Addiction) and Geography – Global Forecast to 2026”. Early buyers will get 10% customization on study.

To Avail deep insights of Psychedelic Drugs Market Size, competition landscape is provided i.e. Revenue Analysis (M $US) by Company (2018-2020), Segment Revenue Market Share (%) by Players (2018-2020) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Unlock new opportunities in Psychedelic Drugs Market; the latest release from MarketDigits highlights the key market trends significant to the growth prospects, Let us know if any specific players or list of players needs to consider to gain better insights.

Grab Complete Details with TOC @

Market Overview

Psychedelic Medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various mental disorders such as resistant depression, panic disorder, opiate addiction, etc.

These are used to change and enhance sensory perceptions, energy levels, thought process, and to facilitate spiritual experiences. Psychedelic Drugs have been used experimentally for psychological treatment to control the mind or maintain peace.

Global Psychedelic Drugs market is growing rapidly due to the increasing number of depression cases and rising special designation from the regulatory authorities to the company to expedite the development process of medicines.

The outbreak of novel coronavirus is believed to have a severe impact on the global Psychedelic Drugs market.

There has been a disruption in the supply chain resulting in a significant shortage in the supply of Psychedelic Drugs across the world.

The import of several API from china has been stopped affecting the production of Psychedelic Drugs. Manufacturing industries are being shuttered around the world due to lockdown causing an unprecedented technology and business model transformation.

Psychedelic Drugs Market: Overview

Based on the drug type, the Lysergic Acid Diethylamide (LSD) is expected to hold a major share in the Psychedelic Drugs market.

Based on the route of administration, the oral route is expected to dominate the Psychedelic Drugs market, followed by injectables and inhalation.

Based on the distribution channel, the hospital pharmacies are expected to be the most profitable segment in the global Psychedelic Drugs market.

Psychedelic Drugs Market: Drivers and Restraints:

The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.

The treatment for psychedelic drugs dependency is also expected to boost the psychedelic market growth. Apart from drivers, there are some factors that restrain the growth of the Psychedelic Drugs market such as wider acceptance of non-therapeutics therapies over pharmacological therapies, strict regulations imposed by the government to commercialize Psychedelic Drugs.

Psychedelic Drugs Market: Key Market Participants

Some of the market participants in the global Psychedelic Drugs Market identified across the value chain include:

  • Roche Holding AG
  • Pfizer Inc.
  • The Emmes Company
  • LLC
  • COMPASS Group plc
  • Merck & Co. Inc.
  • AstraZeneca PLC
  • AbbVie Inc.
  • Mylan N.V.
  • Alkermes plc
  • Dr. Reddy’s Laboratories
  • The Takeda Pharmaceutical Company Limited
  • H. Lundbeck A/S
  • Jonhson & Johnson
  • Numinus Wellness
  • Mota Ventures Corp.
  • Mind medicine (MindMed) Inc.
  • Eli Lilly and Company
  • Teva Pharmceuticals Industries Ltd.
  • Novartis International AG
  • GlaxoSmithKline plc Sanofi

Psychedelic Drugs Market: Region-wise Outlook

North America is expected to dominate the global Psychedelic Drugs market, owing to the higher adoption of Psychedelic Drugs in the region. North America to be followed by Europe, due to the increasing number of psychiatric disorders.

Asia-Pacific is expected to have a significant growth in the global Psychedelic Drugs market over the forecast period, due to the changing lifestyle and increasing environmental stress that is rising the demand of Psychedelic Drugs in the region.

Many companies are entering the Psychedelic Drugs market with their innovations and development. The first Psychedelic Drugs to gain FDA Breakthrough Therapy designation was SPRAVATO (esteketamine) nasal spray developed by Johnson & Johnson to treat resistant depression.

Numinus Wellness Inc., recently became the first publicly-traded company to be granted a licence by Health Canda for extracting psilocybin from mushrooms. MindMed, a neuro-pharmaceutical, is a front-runner moving through clinical trials that are based on LSD, and Ayahuasaca’s active ingredient.

The report covers exhaust analysis on:

  • Psychedelic Drugs Market Segments
  • Psychedelic Drugs Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Psychedelic Drugs Market: Segmentation

Psychedelic Drugs Market: By drug type:

  • Lysergic Acid Diethylamide (LSD)
  • Phencyclidine
  • 3,4-MethylEnedioxyMethamphetamine
  • Ketamine
  • Gamma Hydroxybutyric Acid (GHB)
  • Salvia
  • others

Psychedelic Drugs Market: By administration:

  • Oral
  • Injectable
  • Inhalation

Psychedelic Drugs Market: By distribution channel:

  • Hospital Pharmacies
  • Retailer Pharmacies
  • Online pharmacies
  • Others

Analysis and discussion of important industry trends, market size, market share estimates are also covered in this global  Psychedelic Drugs market report. The usefulness of SWOT analysis & Porter's Five Forces analysis in generating market research report makes it preferable by the businesses and hence also used while preparing this  Psychedelic Drugs report.  Psychedelic Drugs market report consists of market analysis by regions, especially North America, China, Europe, Southeast Asia, Japan, and India, focusing top manufacturers in global market, with production, price, revenue, and market share for each manufacturer. Being the most suitable example of the key market attributes, this  Psychedelic Drugs report has been prepared by keeping in mind every market related aspect.

Which market aspects are illuminated in the report?

Executive Summary: It covers a summary of the most vital studies, the Global  Psychedelic Drugs market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.

Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global  Psychedelic Drugs market, the years measured and the study points.

Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.

Manufacture by region: This Global  Psychedelic Drugs report offers data on imports and exports, sales, production and key companies in all studied regional markets.

Report Highlights:

  • Detailed overview of parent market
  • Changing Psychedelic Drugs market dynamics in the industry
  • Psychedelic Drugs-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Psychedelic Drugs industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Table of Contents:

1 Scope of the Report

2 Executive Summary

3 Global  Psychedelic Drugs by Players

4  Psychedelic Drugs by Regions

5 Americas


7 Europe

8 Middle East & Africa

9 Market Drivers, Challenges and Trends

10 Global  Psychedelic Drugs Market Forecast

11 Key Players Analysis

12 Research Findings and Conclusion

13 List of Tables

14 List of Figures

Top Trending Reports :

Connected Drug Delivery Devices Market 2021 Incredible Possibilities, Growth With Industry Study, Detailed Analysis And Forecast To 2027 | Cohero Health, Sagentia, OPKO Health, 3M Company

Digital Therapeutics Market 2021 to Explore Excellent Growth in Future with a CAGR of 20.5% | Click Therapeutics, Fitbit, Happify, Kaia Health, Livongo Health, Medtronic

Drug Screening Market 2021 Industry Share, Size, Growth, Trends, Top leader | Shimadzu Corporation, Siemens, Alere, and Dragerwerk AG

Gene Therapy Market 2021 Global Industry Insights, Share, Size, COVID-19 Impact, Segmentation, Business Opportunity, and Growth Factor Analysis Research Report 2027

Synthetic Biology Market 2021 Latest Research, Business Overview, Industry Analysis, Driver, Trends and Key Value | Integrated DNA technologies, Eurofins Scientific, Origene technologies

Any Questions? Inquire Here Before Buying @

About Market Digits :

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

Contact Us :


Phone : +91-9822485644

Email :

Global Psychedelic Drugs Market (COVID - 19 Updates) 2021 A look At Current And Upcoming Growth |

Editor Details

Related Links

Last Updated: 09-Mar-2021